Fairmount Funds Management LLC
- SEC CIK
- 0001802528
- Latest filing
- Aug 14, 2026
ATXS holding history
Astria Therapeutics, Inc. in every 13F filed by Fairmount Funds Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATXS overviewAll 13F holders of ATXSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −3,554,129−100.0% | Sold out | Holders |
| Q3 2025 | 3,554,129 | $25.9M | 2.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 3,554,129 | $19.1M | 2.5% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3,554,129 | $19.0M | 2.9% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3,554,129 | $31.8M | 3.2% | 00.0% | Unchanged | Holders |
| Q3 2024 | 3,554,129 | $39.1M | 3.2% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,554,129 | $32.3M | 3.7% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,554,129 | $50.0M | 5.5% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,554,129 | $27.3M | 2.9% | +1,652,732+86.9% | Added | Holders |
| Q3 2023 | 1,901,397 | $14.2M | 1.7% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,901,397 | $15.8M | 2.2% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,901,397 | $25.3M | 4.3% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,901,397 | $28.3M | 4.5% | +989,661+108.5% | Added | Holders |
| Q3 2022 | 911,736 | $8.24M | 1.5% | 00.0% | Unchanged | Holders |
| Q2 2022 | 911,736 | $2.73M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2022 | 911,736 | $6.12M | 1.4% | 00.0% | Unchanged | Holders |
| Q4 2021 | 911,736 | $4.91M | 1.6% | 00.0% | Unchanged | Holders |
| Q3 2021 | 911,736 | $8.06M | 2.9% | +911,736 | New | Holders |